Showing results (51-60 of 386) with videos related to
Sort By:
Pageof 39
JCI Insight|February 22, 2024
Critical and distinct roles of cell type-specific NF-κB2 in lung cancerFan Sun, Yadong Xiao, Steven D Shapiro, et al.The International Journal of Biochemistry & Cell Biology|October 16, 2002
Sepsis: current concepts in intracellular signalingDerek Strassheim, Jong Sung Park, Edward AbrahamShock (Augusta, Ga.)|October 6, 2005
Genetic polymorphisms and sepsisJohn Arcaroli, Michael B Fessler, Edward AbrahamJournal of Pediatric Orthopedics|November 19, 2005
Management of supracondylar fractures of humerus with condylar involvement in childrenEdward Abraham, Alexander Gordon, Omar Abdul-HadiFASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 16, 2008
Interleukin-1 receptor-associated kinase (IRAK) -1-mediated NF-kappaB activation requires cytosolic and nuclear activityGang Liu, Young-Jun Park, Edward AbrahamJournal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
Deletion of secretory group V phospholipase A2 attenuates cell migration and airway hyperresponsiveness in immunosensitized miceNilda M Muñoz, Angelo Y Meliton, Jonathan P Arm, et al.Journal of Pediatric Orthopedics|August 17, 2004
Musculoskeletal manifestations of Russell-Silver syndromeEdward Abraham, Haluk Altiok, John P LubickyAntimicrobial Agents and Chemotherapy|May 27, 2005
Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically ill patientsDouglas N Fish, Isaac Teitelbaum, Edward AbrahamThe Journal of Biological Chemistry|June 25, 2009
S-glutathionylation of the Rpn2 regulatory subunit inhibits 26 S proteasomal functionJaroslaw W Zmijewski, Sami Banerjee, Edward AbrahamAmerican Journal of Respiratory Cell and Molecular Biology|May 8, 2010
Group V phospholipase A2 mediates barrier disruption of human pulmonary endothelial cells caused by LPS in vitroSteven M Dudek, Nilda M Muñoz, Anjali Desai, et al.Pageof 39